Metagenomi Therapeutics MGX
NASDAQ MGX
$1.10 -0.03 (-2.65%)
As of: Sep 30, 2026 · 1:28 PM EDT

Metagenomi Therapeutics, Inc. (MGX) EPS (Diluted) (2023 - 2026)

Updated

Metagenomi Therapeutics (MGX) recorded EPS (Diluted) of -$0.73 in Q2 2026, compared with -$0.54 a year earlier.

Analysis

Metagenomi Therapeutics, Inc. (MGX) EPS (Diluted) (2023 - 2026) Analysis & Trends

On a TTM basis, Metagenomi Therapeutics' EPS (Diluted) came in at -$2.48 as of Jun 30, 2026; for FY2025, it came in at -$2.36.

  • Across earlier years, EPS (Diluted) came in at -$2.36 in FY2024 and -$20.05 in FY2023.
  • The Q2 2026 figure is the lowest quarterly EPS (Diluted) since Q1 2024.
  • Per Business Quant, the preceding three quarters came in at -$0.61 (Q1 2026), -$0.60 (Q4 2025) and -$0.55 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.73
Mar 31, 2026 -0.61
Dec 31, 2025 -0.60
Sep 30, 2025 -0.55
Jun 30, 2025 -0.54
Mar 31, 2025 -0.68
Dec 31, 2024 -0.71
Sep 30, 2024 -0.51
Jun 30, 2024 -0.29
Mar 31, 2024 -1.19
Dec 31, 2023 -5.67
Sep 30, 2023 -5.82
Jun 30, 2023 -3.82
Mar 31, 2023 -4.74
API Access

Metagenomi Therapeutics, Inc. EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=MGX&period=max&api_key=YOUR_API_KEY